Hebebrand J - Search Results

1

No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation.

Theisen FM, Haberhausen M, Firnges MA, Gregory P, Reinders JH, Remschmidt H, Hebebrand J, Antel J. Theisen FM, et al. Among authors: hebebrand j. Pharmacogenomics J. 2007 Aug;7(4):275-81. doi: 10.1038/sj.tpj.6500418. Epub 2006 Sep 19. Pharmacogenomics J. 2007. PMID: 16983399

2

Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine.

Theisen FM, Linden A, König IR, Martin M, Remschmidt H, Hebebrand J. Theisen FM, et al. Among authors: hebebrand j. J Neural Transm (Vienna). 2003 Jan;110(1):111-21. doi: 10.1007/s00702-002-0792-6. J Neural Transm (Vienna). 2003. PMID: 12541016

3

Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders.

Gebhardt S, Haberhausen M, Krieg JC, Remschmidt H, Heinzel-Gutenbrunner M, Hebebrand J, Theisen FM. Gebhardt S, et al. Among authors: hebebrand j. J Neural Transm (Vienna). 2007;114(8):1091-5. doi: 10.1007/s00702-007-0663-2. Epub 2007 Mar 20. J Neural Transm (Vienna). 2007. PMID: 17372672

4

Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study.

Gebhardt S, Theisen FM, Haberhausen M, Heinzel-Gutenbrunner M, Wehmeier PM, Krieg JC, Kühnau W, Schmidtke J, Remschmidt H, Hebebrand J. Gebhardt S, et al. Among authors: hebebrand j. J Clin Pharm Ther. 2010 Apr;35(2):207-11. doi: 10.1111/j.1365-2710.2009.01084.x. J Clin Pharm Ther. 2010. PMID: 20456740

5

[Body weight under genetic control].

Hebebrand J, Remschmidt H. Hebebrand J, et al. Med Klin (Munich). 1995 Jul 15;90(7):403-10. Med Klin (Munich). 1995. PMID: 7675005 Review. German. No abstract available.

6

Candidate gene polymorphisms in eating disorders.

Hinney A, Remschmidt H, Hebebrand J. Hinney A, et al. Among authors: hebebrand j. Eur J Pharmacol. 2000 Dec 27;410(2-3):147-159. doi: 10.1016/s0014-2999(00)00812-8. Eur J Pharmacol. 2000. PMID: 11134666 Review.

7

Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication.

Theisen FM, Linden A, Geller F, Schäfer H, Martin M, Remschmidt H, Hebebrand J. Theisen FM, et al. Among authors: hebebrand j. J Psychiatr Res. 2001 Nov-Dec;35(6):339-45. doi: 10.1016/s0022-3956(01)00041-3. J Psychiatr Res. 2001. PMID: 11684141

8

A prospective study of serum ghrelin levels in patients treated with clozapine.

Theisen FM, Gebhardt S, Brömel T, Otto B, Heldwein W, Heinzel-Gutenbrunner M, Krieg JC, Remschmidt H, Tschöp M, Hebebrand J. Theisen FM, et al. Among authors: hebebrand j. J Neural Transm (Vienna). 2005 Oct;112(10):1411-6. doi: 10.1007/s00702-005-0284-6. Epub 2005 Jun 15. J Neural Transm (Vienna). 2005. PMID: 15959857 Clinical Trial.

9

Anorexia nervosa viewed as an extreme weight condition: genetic implications.

Hebebrand J, Remschmidt H. Hebebrand J, et al. Hum Genet. 1995 Jan;95(1):1-11. doi: 10.1007/BF00225065. Hum Genet. 1995. PMID: 7814009

10

Serum leptin levels increase rapidly after initiation of clozapine therapy.

Brömel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg JC, Hebebrand J. Brömel T, et al. Among authors: hebebrand j. Mol Psychiatry. 1998 Jan;3(1):76-80. doi: 10.1038/sj.mp.4000352. Mol Psychiatry. 1998. PMID: 9491817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

650 results

Search Page